- Home
- MYGN vs BSRR Comparison
MYGN vs BSRR Comparison
Compare MYGN & BSRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- BSRR
- Stock Information
- Founded
- MYGN 1991
- BSRR 1977
- Country
- MYGN United States
- BSRR United States
- Employees
- MYGN N/A
- BSRR N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BSRR Major Banks
- Sector
- MYGN Health Care
- BSRR Finance
- Exchange
- MYGN Nasdaq
- BSRR Nasdaq
- Market Cap
- MYGN 423.1M
- BSRR 416.7M
- IPO Year
- MYGN 1995
- BSRR 1994
- Fundamental
- Price
- MYGN $7.64
- BSRR $30.26
- Analyst Decision
- MYGN Hold
- BSRR Buy
- Analyst Count
- MYGN 13
- BSRR 2
- Target Price
- MYGN $13.50
- BSRR $33.50
- AVG Volume (30 Days)
- MYGN 1.4M
- BSRR 22.6K
- Earning Date
- MYGN 11-06-2025
- BSRR 10-20-2025
- Dividend Yield
- MYGN N/A
- BSRR 3.33%
- EPS Growth
- MYGN N/A
- BSRR 18.55
- EPS
- MYGN N/A
- BSRR 2.90
- Revenue
- MYGN $832,900,000.00
- BSRR $145,369,000.00
- Revenue This Year
- MYGN $0.17
- BSRR $8.30
- Revenue Next Year
- MYGN $6.19
- BSRR $3.74
- P/E Ratio
- MYGN N/A
- BSRR $10.35
- Revenue Growth
- MYGN 3.83
- BSRR 2.12
- 52 Week Low
- MYGN $3.76
- BSRR $22.42
- 52 Week High
- MYGN $29.30
- BSRR $35.13
- Technical
- Relative Strength Index (RSI)
- MYGN 75.45
- BSRR 51.76
- Support Level
- MYGN $6.73
- BSRR $29.83
- Resistance Level
- MYGN $7.05
- BSRR $30.92
- Average True Range (ATR)
- MYGN 0.38
- BSRR 0.60
- MACD
- MYGN 0.10
- BSRR -0.02
- Stochastic Oscillator
- MYGN 94.31
- BSRR 32.09
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About BSRR Sierra Bancorp
Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.